Light Emitting Diode in the Treatment of Vulvodynia

Status Recruiting

Clinical Trial Summary

Vulvar pain can be related to a specific cause (inflammation, cancer, trauma, infection) or can be classified as vulvodynia, when vulvar pain is idiopathic and lasts for at least three months. The main symptoms reported are pain, burning, erythema, increased sensitivity, itching and burning, which affect the quality of life, psycho-emotional well-being, relationships and sexual function of these women. Photobiomodulation has been described in the literature as an alternative to treat pain. Our group has studied blue LED for some vulvovaginal dysfunctions and, due to the positive sensory effects observed in patients with vaginal stenosis and genitourinary syndrome of menopause, it is hypothesized that this technique could also bring beneficial effects for women with vulvodynia. A pilot study will be carried out, with descriptive data, with 10 women with vulvodynia. Participants will be evaluated with a basic anamnestic questionnaire and sociodemographic data. The following questionnaires will be used: Female Sexual Function Index (FSFI), Sexual Quotient - Female Version, Vulvar Pain Assessment Questionnaire. After answering the questionnaires, the volunteer will undergo a perineal physical assessment by an experienced physiotherapist, which includes a) inspection of the genital region, reflex tests, assessment of the functions of the pelvic floor muscles, b) the cotton swab test to evaluate painful sensitivity in the vestibule, c) the tampon test to evaluate painful sensitivity in the introitus and vaginal canal. Pain assessments will be quantified by the visual analogue pain scale (VAS), which ranges from 0 (no pain) to 10 (maximum pain). At the end of the treatment, the participant will answer the questionnaires again, undergo reassessment of pain sensitivity in vulva, introitus and vaginal canal, of the function of the pelvic floor muscles and will be asked "What is your perception of improvement" and "What is your level of satisfaction with the treatment?". The answers will be giving according to a Likert Scale of five points. The LED application protocol will be carried out with external use equipment model Antares, from the company IBRAMED (Amparo, São Paulo, Brazil), with a cluster G2 applicator. The power will be 450mW/cm2 and dose 5J/cm2 for 2 minutes and 13 seconds (automatic programming) in 450nm waves (blue wavelength). The treatment consists of eight sessions, carried out daily, except on weekends.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Vulvodynia

Clinical Trial Details

NCT number	NCT06337448
Study type	Interventional
Source	Centro de Atenção ao Assoalho Pélvico
Contact	Patricia V Lordelo, Phd
Phone	+5571996592400
Email	pvslordelo@hotmail.com
Status	Recruiting
Phase	N/A
Start date	January 16, 2024
Completion date	December 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05478746` - Effects of Flourish HEC on Localized Provoked Vulvodynia	N/A
Completed	`NCT02404961` - Women's Health Study: Immunological Factors and Risk of Vulvodynia
Completed	`NCT00751010` - Relationship: Interstitial Cystitis & Vulvodynia-Part 2	N/A
Completed	`NCT00607490` - A Randomized Clinical Trial for Women With Vulvodynia	N/A
Recruiting	`NCT03640624` - Multidisciplinary Treatment of Chronic Vulvar Pain	N/A
Recruiting	`NCT05343182` - Vestibulectomy Surgical Techniques Comparison Study	N/A
Recruiting	`NCT05518630` - An Investigation of Nomothetic Versus Idiographic Assessment in Chronic Pain
Recruiting	`NCT05597358` - Efficacy of High Intensity Laser for Provoked Vestibulodynia	N/A
Completed	`NCT01304589` - Savella in Treatment for Provoked Vestibulodynia	Phase 3
Completed	`NCT00590590` - Safety and Efficacy of Two Vaginal Products Versus Placebo in Patients With Vaginal Discomfort	Phase 2
Recruiting	`NCT06138171` - Personality, Defences, Central Sensitization, and Trauma in Women With Chronic Migraine, Fibromyalgia, and Vulvodynia
Completed	`NCT01996384` - Provoked, Localized Vulvodynia Treatment With Acupuncture and Lidocaine Pilot Study	Phase 1
Completed	`NCT01664962` - Search for Genetic Basis of Vulvodynia	N/A
Recruiting	`NCT05955313` - Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia	Phase 2
Completed	`NCT02773641` - Placebo-controlled RCT of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia	Phase 3
Completed	`NCT00501774` - A Search for Helicobacter Pylori in Localized Vulvodynia	N/A
Completed	`NCT04057755` - Botulinum Toxin A as a Treatment for Provoked Vestibulodynia	Phase 3
Terminated	`NCT04016467` - Effect of Spinal Manipulation on Vulvar Pain	N/A
Completed	`NCT01935063` - Study to Compare the Efficacy of Cognitive-behavioral Couple Therapy and Lidocaine for Provoked Vestibulodynia	N/A
Completed	`NCT02809612` - An Internet-based Information Platform for Vulvodynia Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.